GFPT1: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Underlinked|date=March 2014}} | |||
{{ | |||
| | |||
}} | |||
{{Infobox_gene}} | |||
{{ | '''Glucosamine—fructose-6-phosphate aminotransferase isomerizing 1''' is an [[enzyme]] that in humans is encoded by the ''GFPT1'' [[gene]].<ref name="pmid1460020">{{cite journal |vauthors=McKnight GL, Mudri SL, Mathewes SL, Traxinger RR, Marshall S, Sheppard PO, O'Hara PJ | title = Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase | journal = J Biol Chem | volume = 267 | issue = 35 | pages = 25208–12 |date=Jan 1993 | pmid = 1460020 | pmc = | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: GFPT1 glutamine-fructose-6-phosphate transaminase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2673| accessdate = }}</ref> | ||
| | |||
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | <!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. --> | ||
{{PBB_Summary | {{PBB_Summary | ||
| section_title = | | section_title = | ||
| summary_text = Glutamine-fructose-6-phosphate transaminase 1 is the first and rate-limiting enzyme of the hexosamine pathway. GFAT controls the flux of glucose into the hexosamine pathway and catalyzes the formation of glucosamine 6-phosphate.<ref name="entrez" | | summary_text = [[Glutamine]]-[[fructose]]-6-[[phosphate]] transaminase 1 is the first and rate-limiting enzyme of the [[hexosamine]] pathway. GFAT controls the flux of [[glucose]] into the hexosamine pathway and [[catalyzes]] the formation of [[glucosamine]] 6-phosphate.<ref name="entrez" /> | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal |vauthors=Schleicher ED, Weigert C |title=Role of the hexosamine biosynthetic pathway in diabetic nephropathy |journal=Kidney Int. Suppl. |volume=77 |issue= |pages= S13–8 |year= 2001 |pmid= 10997685 |doi= }} | ||
*{{cite journal | | *{{cite journal |vauthors=Traxinger RR, Marshall S |title=Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation |journal=J. Biol. Chem. |volume=266 |issue= 16 |pages= 10148–54 |year= 1991 |pmid= 2037571 |doi= }} | ||
*{{cite journal | | *{{cite journal |vauthors=Whitmore TE, Mudri SL, McKnight GL |title=Physical mapping of the human glutamine:fructose-6-phosphate amidotransferase gene (GFPT) to chromosome 2p13 |journal=Genomics |volume=26 |issue= 2 |pages= 422–3 |year= 1995 |pmid= 7601477 |doi=10.1016/0888-7543(95)80235-E }} | ||
*{{cite journal | author= | *{{cite journal | author=Zhou J |title=Human glutamine: fructose-6-phosphate amidotransferase: characterization of mRNA and chromosomal assignment to 2p13 |journal=Hum. Genet. |volume=96 |issue= 1 |pages= 99–101 |year= 1995 |pmid= 7607664 |doi=10.1007/BF00214194 |name-list-format=vanc| author2=Neidigh JL | author3=Espinosa R | display-authors=3 | last4=Lebeau | first4=Michelle M. | last5=McClain | first5=Donald A. }} | ||
*{{cite journal |vauthors=Sayeski PP, Paterson AJ, Kudlow JE |title=The murine glutamine:fructose-6-phosphate amidotransferase-encoding cDNA sequence |journal=Gene |volume=140 |issue= 2 |pages= 289–90 |year= 1994 |pmid= 8144040 |doi=10.1016/0378-1119(94)90560-6 }} | |||
*{{cite journal | | *{{cite journal | author=Nerlich AG |title=Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes |journal=Diabetes |volume=47 |issue= 2 |pages= 170–8 |year= 1998 |pmid= 9519709 |doi=10.2337/diabetes.47.2.170 |name-list-format=vanc| author2=Sauer U | author3=Kolm-Litty V | display-authors=3 | last4=Wagner | first4=E. | last5=Koch | first5=M. | last6=Schleicher | first6=E. D. }} | ||
*{{cite journal | author=Nerlich AG | *{{cite journal | author=Oki T |title=cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse |journal=Genomics |volume=57 |issue= 2 |pages= 227–34 |year= 1999 |pmid= 10198162 |doi= 10.1006/geno.1999.5785 |name-list-format=vanc| author2=Yamazaki K | author3=Kuromitsu J | display-authors=3 | last4=Okada | first4=M | last5=Tanaka | first5=I }} | ||
*{{cite journal | author=Chang Q |title=Phosphorylation of human glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity |journal=J. Biol. Chem. |volume=275 |issue= 29 |pages= 21981–7 |year= 2000 |pmid= 10806197 |doi= 10.1074/jbc.M001049200 |name-list-format=vanc| author2=Su K | author3=Baker JR | display-authors=3 | last4=Yang | first4=X | last5=Paterson | first5=AJ | last6=Kudlow | first6=JE }} | |||
*{{cite journal | author= | *{{cite journal | author=Niimi M |title=Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle |journal=J. Hum. Genet. |volume=46 |issue= 10 |pages= 566–71 |year= 2001 |pmid= 11587069 |doi=10.1007/s100380170022 |name-list-format=vanc| author2=Ogawara T | author3=Yamashita T | display-authors=3 | last4=Yamamoto | first4=Y. | last5=Ueyama | first5=A. | last6=Kambe | first6=T. | last7=Okamoto | first7=T. | last8=Ban | first8=T. | last9=Tamanoi | first9=H. }} | ||
*{{cite journal |vauthors=DeHaven JE, Robinson KA, Nelson BA, Buse MG |title=A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle |journal=Diabetes |volume=50 |issue= 11 |pages= 2419–24 |year= 2001 |pmid= 11679416 |doi=10.2337/diabetes.50.11.2419 }} | |||
*{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |name-list-format=vanc| author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} | |||
*{{cite journal | author= | *{{cite journal | author=Weigert C |title=Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells |journal=Diabetologia |volume=46 |issue= 6 |pages= 852–5 |year= 2004 |pmid= 12802498 |doi= 10.1007/s00125-003-1122-8 |name-list-format=vanc| author2=Friess U | author3=Brodbeck K | display-authors=3 | last4=h�Ring | first4=H. U. | last5=Schleicher | first5=E. D. }} | ||
*{{cite journal | author=Ng DP |title=Scrutiny of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) locus reveals conserved haplotype block structure not associated with diabetic nephropathy |journal=Diabetes |volume=53 |issue= 3 |pages= 865–9 |year= 2004 |pmid= 14988277 |doi=10.2337/diabetes.53.3.865 |name-list-format=vanc| author2=Walker WH | author3=Chia KS | display-authors=3 | last4=Choo | first4=S. | last5=Warram | first5=J. H. | last6=Krolewski | first6=A. S. }} | |||
*{{cite journal | author=Elbein SC |title=Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy |journal=Mol. Genet. Metab. |volume=82 |issue= 4 |pages= 321–8 |year= 2005 |pmid= 15308130 |doi= 10.1016/j.ymgme.2004.05.004 |name-list-format=vanc| author2=Zheng H | author3=Jia Y | display-authors=3 | last4=Chu | first4=Winston | last5=Cooper | first5=Judith J. | last6=Hale | first6=Terri | last7=Zhang | first7=Zhengxian }} | |||
*{{cite journal | author= | *{{cite journal | author=Gerhard DS |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |name-list-format=vanc| author2=Wagner L | author3=Feingold EA | display-authors=3 | last4=Shenmen | first4=CM | last5=Grouse | first5=LH | last6=Schuler | first6=G | last7=Klein | first7=SL | last8=Old | first8=S | last9=Rasooly | first9=R }} | ||
*{{cite journal | author=Chou KC |title=Molecular therapeutic target for type-2 diabetes |journal=J. Proteome Res. |volume=3 |issue= 6 |pages= 1284–8 |year= 2005 |pmid= 15595739 |doi= 10.1021/pr049849v }} | |||
*{{cite journal | author= | *{{cite journal | author=Weigert C |title=The -913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects |journal=J. Clin. Endocrinol. Metab. |volume=90 |issue= 3 |pages= 1639–43 |year= 2005 |pmid= 15613432 |doi= 10.1210/jc.2004-0058 |name-list-format=vanc| author2=Thamer C | author3=Brodbeck K | display-authors=3 | last4=Guirguis | first4=A | last5=Machicao | first5=F | last6=Machann | first6=J | last7=Schick | first7=F | last8=Stumvoll | first8=M | last9=Fritsche | first9=A }} | ||
*{{cite journal | author=Burt D |title=Partial characterisation of the human GFAT promoter: effect of single nucleotide polymorphisms on promoter function |journal=Biochim. Biophys. Acta |volume=1740 |issue= 1 |pages= 85–90 |year= 2005 |pmid= 15878746 |doi= 10.1016/j.bbadis.2005.01.007 |name-list-format=vanc| author2=Brodbeck K | author3=Häring HU | display-authors=3 | last4=Schleicher | first4=Erwin D. | last5=Weigert | first5=Cora }} | |||
*{{cite journal | author= | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{ | <!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | ||
{{ | {{PBB_Controls | ||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{gene-2-stub}} |
Revision as of 08:44, 31 August 2017
This article needs more links to other articles to help integrate it into the encyclopedia. (March 2014) (Learn how and when to remove this template message) |
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Glucosamine—fructose-6-phosphate aminotransferase isomerizing 1 is an enzyme that in humans is encoded by the GFPT1 gene.[1][2]
Glutamine-fructose-6-phosphate transaminase 1 is the first and rate-limiting enzyme of the hexosamine pathway. GFAT controls the flux of glucose into the hexosamine pathway and catalyzes the formation of glucosamine 6-phosphate.[2]
References
- ↑ McKnight GL, Mudri SL, Mathewes SL, Traxinger RR, Marshall S, Sheppard PO, O'Hara PJ (Jan 1993). "Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase". J Biol Chem. 267 (35): 25208–12. PMID 1460020.
- ↑ 2.0 2.1 "Entrez Gene: GFPT1 glutamine-fructose-6-phosphate transaminase 1".
Further reading
- Schleicher ED, Weigert C (2001). "Role of the hexosamine biosynthetic pathway in diabetic nephropathy". Kidney Int. Suppl. 77: S13–8. PMID 10997685.
- Traxinger RR, Marshall S (1991). "Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation". J. Biol. Chem. 266 (16): 10148–54. PMID 2037571.
- Whitmore TE, Mudri SL, McKnight GL (1995). "Physical mapping of the human glutamine:fructose-6-phosphate amidotransferase gene (GFPT) to chromosome 2p13". Genomics. 26 (2): 422–3. doi:10.1016/0888-7543(95)80235-E. PMID 7601477.
- Zhou J, Neidigh JL, Espinosa R, et al. (1995). "Human glutamine: fructose-6-phosphate amidotransferase: characterization of mRNA and chromosomal assignment to 2p13". Hum. Genet. 96 (1): 99–101. doi:10.1007/BF00214194. PMID 7607664.
- Sayeski PP, Paterson AJ, Kudlow JE (1994). "The murine glutamine:fructose-6-phosphate amidotransferase-encoding cDNA sequence". Gene. 140 (2): 289–90. doi:10.1016/0378-1119(94)90560-6. PMID 8144040.
- Nerlich AG, Sauer U, Kolm-Litty V, et al. (1998). "Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes". Diabetes. 47 (2): 170–8. doi:10.2337/diabetes.47.2.170. PMID 9519709.
- Oki T, Yamazaki K, Kuromitsu J, et al. (1999). "cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse". Genomics. 57 (2): 227–34. doi:10.1006/geno.1999.5785. PMID 10198162.
- Chang Q, Su K, Baker JR, et al. (2000). "Phosphorylation of human glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity". J. Biol. Chem. 275 (29): 21981–7. doi:10.1074/jbc.M001049200. PMID 10806197.
- Niimi M, Ogawara T, Yamashita T, et al. (2001). "Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle". J. Hum. Genet. 46 (10): 566–71. doi:10.1007/s100380170022. PMID 11587069.
- DeHaven JE, Robinson KA, Nelson BA, Buse MG (2001). "A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle". Diabetes. 50 (11): 2419–24. doi:10.2337/diabetes.50.11.2419. PMID 11679416.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Weigert C, Friess U, Brodbeck K, et al. (2004). "Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells". Diabetologia. 46 (6): 852–5. doi:10.1007/s00125-003-1122-8. PMID 12802498. replacement character in
|last4=
at position 2 (help) - Ng DP, Walker WH, Chia KS, et al. (2004). "Scrutiny of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) locus reveals conserved haplotype block structure not associated with diabetic nephropathy". Diabetes. 53 (3): 865–9. doi:10.2337/diabetes.53.3.865. PMID 14988277.
- Elbein SC, Zheng H, Jia Y, et al. (2005). "Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy". Mol. Genet. Metab. 82 (4): 321–8. doi:10.1016/j.ymgme.2004.05.004. PMID 15308130.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Chou KC (2005). "Molecular therapeutic target for type-2 diabetes". J. Proteome Res. 3 (6): 1284–8. doi:10.1021/pr049849v. PMID 15595739.
- Weigert C, Thamer C, Brodbeck K, et al. (2005). "The -913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects". J. Clin. Endocrinol. Metab. 90 (3): 1639–43. doi:10.1210/jc.2004-0058. PMID 15613432.
- Burt D, Brodbeck K, Häring HU, et al. (2005). "Partial characterisation of the human GFAT promoter: effect of single nucleotide polymorphisms on promoter function". Biochim. Biophys. Acta. 1740 (1): 85–90. doi:10.1016/j.bbadis.2005.01.007. PMID 15878746.
This article on a gene on human chromosome 2 is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with broken file links
- Articles with too few wikilinks from March 2014
- Articles with invalid date parameter in template
- All articles with too few wikilinks
- Articles covered by WikiProject Wikify from March 2014
- All articles covered by WikiProject Wikify
- Genes on human chromosome
- CS1 errors: invisible characters
- All stub articles
- Human chromosome 2 gene stubs